‘PTCy – for ALL donors?’ w. Leo Luznik

In this episode Prof. Leo Luznik will describe how post-transplant cyclophosphamide as effective GvHD prophylaxis was detected and used after haploidentical allogeneic transplantation and its current and future role in HLA identical sibling, as well as in matched and mismatched unrelated stem cell transplantation. SUBSCRIBE TO MAILINGLIST https://www.mythsandfactspodcast.com LISTEN TO THE PODCAST https://open.spotify.com/show/033tJ34... -- Leo Luznik is a Chief of Hematology and Oncology, Professor at the Department of Medicine and Physician in Chief, Dan L. Duncan CCC Baylor College of Medicine, Houston, USA. His primary research and clinical interests are in the area of allogeneic bone marrow transplantation. Beside conducting clinical trials, Leo Luznik is running active laboratory research program, focused on the mechanisms of GvHD prevention with posttransplant cyclophosphamide and immunotherapy of acute leukemias.